Cannabinoide, wie z. B. Cannabidiol, sind therapeutisch sehr vielversprechend. Die derzeit verfügbaren Verabreichungsformate sowie die laufende Forschung und Entwicklung (&) stehen jedoch vor Herausforderungen in Bezug auf die Wirkstoffabsorption und die Compliance der Patienten. In diesem Webinar teilen wir die Erkenntnisse aus einer eingehenden Technologiebewertung zur Verbesserung der Bioverfügbarkeit von CBD bei gleichzeitiger Ermöglichung patientenfreundlicher Formate mit hohem Wirkstoffgehalt.
Redner:
Explore what newly published CBtru® pharmacokinetic data means for solid oral drug development—and why clinical evidence underpins meaningful innovation.
Explore how dsm-firmenich can help pharma raise the bar in patient-centricity and sustainability.
New study confirms CBtru®, a novel CBD drug product intermediate, demonstrates equal bioavailability to leading oil-based CBD drug product.
Have an idea for a new project, a groundbreaking innovation, or a need for expert services? Let’s talk.
Don’t just take our word for it. Discover how our solutions can support your product development journey.
Customized blends of functional ingredients in one single, efficient premix.
Streamline your product development process and get to market faster.
From trade shows to conferences and other industry events, find out where you can meet us next.
Talking Nutrition, Health & Care
Explore new science, consumer insights, industry news and more in our latest articles.
Discover educational whitepapers, webinars, publications and technical information.
Request samples, place orders and view product documentation.